echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Food News > Nutrition News > A blocked nose may also be cancer, so don’t ignore early screening for high-risk groups

    A blocked nose may also be cancer, so don’t ignore early screening for high-risk groups

    • Last Update: 2021-08-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Science and Technology Daily reporter Chen Xi

    Recently, Hong Kong's well-known director Chen Musheng died of advanced nasopharyngeal cancer


    In this regard, Wang Peiguo, member of the Standing Committee of the Chinese Anti-Cancer Association Nasopharyngeal Carcinoma Professional Committee and deputy director of the Radiotherapy Department of Tianjin Cancer Hospital, said that nasopharyngeal cancer is easily misdiagnosed or missed due to its hidden location and variable or inconspicuous early symptoms


    Don't ignore these early symptoms of nasopharyngeal cancer

    Nasopharyngeal carcinoma is a malignant tumor that occurs on the top and side walls of the nasopharyngeal cavity and nasopharyngeal mucosa


    "The symptoms of nasopharyngeal cancer can be summarized as seven main symptoms: blocked nose, tinnitus, deafness, bloody nose, headache, facial numbness, and diplopia


    Colds, rhinitis, etc.


    "Uncovering the Secret" Causes of the High Incidence of Nasopharyngeal Cancer

    "At present, there is no specific cause of nasopharyngeal carcinoma, but three factors have been determined to be related to nasopharyngeal carcinoma: Epstein-Barr virus infection, geographic region and genetics


    "But not all people infected with Epstein-Barr virus will get nasopharyngeal cancer


    "Region is also an important factor.


    In 2019, a paper published by a team of scientists from China and Singapore in Nature Genetics proposed that 80% of nasopharyngeal cancer patients in Guangdong have a unique high-risk virus subtype, called BALF2_CCT subtype


    The influence of genetic factors on nasopharyngeal carcinoma was also discovered in 2002 and 2010.


    "In addition, there are clinically some patients with nasopharyngeal cancer who have long-term exposure to chemical coatings and inhalation of toxic and harmful substances


    Radiotherapy can make the five-year survival rate of early nasopharyngeal cancer exceed 90%

    "Although the etiology of nasopharyngeal carcinoma is not clear at present, primary prevention cannot be carried out to prevent its occurrence, but there are still many good ways to treat nasopharyngeal carcinoma and early screening


    "Through radiotherapy, the five-year survival rate for early-stage nasopharyngeal cancer can reach more than 90%, and the combined treatment of radiotherapy, chemotherapy and targeted therapy can also reach about 60% for


    Therefore, through screening, the early detection of nasopharyngeal cancer is very important for the treatment effect


    "In addition, in daily life, pay attention to maintaining nasal cavity hygiene, washing hands frequently, not




    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.